Cyclic compounds
AssigneeTanabe Seiyaku Co., Ltd.
InventorsKoichiro Yamada, Kenji Matsuki, Kenji Omori, Kohei Kikkawa
Life of this patent
Estimating the term…
Loading patent…
AssigneeTanabe Seiyaku Co., Ltd.
InventorsKoichiro Yamada, Kenji Matsuki, Kenji Omori, Kohei Kikkawa
Estimating the term…
A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, 1 wherein X is ═CH— or ═N—, Y is —NH—, —NR4—, —S—, —O—, —CH═N—, —N═CH—, —N═N—, —CH═CH—, etc., R1 is a lower alkoxy group, an amino group, a heterocyclic ring containing N atom(s), or a hydroxy group substituted by a heterocyclic ring containing N atom(s) (each of which is optionally substituted), R2 is a lower alkylamino group which is optionally substituted by an aryl group, a lower alkoxy group which is optionally substituted by an aryl group, a lower alkoxy group substituted by an aromatic heterocyclic ring containing N atom(s), R3 is an aryl group, a heterocyclic ring containing N atom(s), a lower alkyl group, a lower alkoxy group, a cyclo lower alkoxy group, a hydroxy group substituted by a heterocyclic ring containing N atom(s), or an amino group (each of which is optionally substituted), and R3 and a substituent in Y may be combined to form a lactone ring. The compound of the present invention has excellent selective PDE V inhibitory activity and therefore, is useful as a therapeutic or prophylactic drug for treating various diseases due to functional disorders on cGMP-signaling.
A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof,
Dependencies are inferred from the claim text.